Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness of mRNA vaccines and waning of protection against SARS-CoV-2 infection and severe covid-19 during predominant circulation of the delta variant in Italy: retrospective cohort study.
Fabiani M, Puopolo M, Morciano C, Spuri M, Spila Alegiani S, Filia A, D'Ancona F, Del Manso M, Riccardo F, Tallon M, Proietti V, Sacco C, Massari M, Da Cas R, Mateo-Urdiales A, Siddu A, Battilomo S, Bella A, Palamara AT, Popoli P, Brusaferro S, Rezza G, Menniti Ippolito F, Pezzotti P; Italian Integrated Surveillance of covid-19 study group and Italian covid-19 Vaccines Registry group. Fabiani M, et al. Among authors: battilomo s. BMJ. 2022 Feb 10;376:e069052. doi: 10.1136/bmj-2021-069052. BMJ. 2022. PMID: 35144968 Free PMC article.
Effectiveness of an mRNA vaccine booster dose against SARS-CoV-2 infection and severe COVID-19 in persons aged ≥60 years and other high-risk groups during predominant circulation of the delta variant in Italy, 19 July to 12 December 2021.
Fabiani M, Puopolo M, Filia A, Sacco C, Mateo-Urdiales A, Spila Alegiani S, Del Manso M, D'Ancona F, Vescio F, Bressi M, Petrone D, Spuri M, Rota MC, Massari M, Da Cas R, Morciano C, Stefanelli P, Bella A, Tallon M, Proietti V, Siddu A, Battilomo S, Palamara AT, Popoli P, Brusaferro S, Rezza G, Riccardo F, Menniti Ippolito F, Pezzotti P. Fabiani M, et al. Among authors: battilomo s. Expert Rev Vaccines. 2022 Jul;21(7):975-982. doi: 10.1080/14760584.2022.2064280. Epub 2022 Apr 15. Expert Rev Vaccines. 2022. PMID: 35389748 Free PMC article.
Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
Sacco C, Del Manso M, Mateo-Urdiales A, Rota MC, Petrone D, Riccardo F, Bella A, Siddu A, Battilomo S, Proietti V, Popoli P, Menniti Ippolito F, Palamara AT, Brusaferro S, Rezza G, Pezzotti P, Fabiani M; Italian National COVID-19 Integrated Surveillance System and the Italian COVID-19 vaccines registry. Sacco C, et al. Among authors: battilomo s. Lancet. 2022 Jul 9;400(10346):97-103. doi: 10.1016/S0140-6736(22)01185-0. Epub 2022 Jul 1. Lancet. 2022. PMID: 35780801 Free PMC article.
Risk of SARS-CoV-2 infection and subsequent hospital admission and death at different time intervals since first dose of COVID-19 vaccine administration, Italy, 27 December 2020 to mid-April 2021.
Mateo-Urdiales A, Spila Alegiani S, Fabiani M, Pezzotti P, Filia A, Massari M, Riccardo F, Tallon M, Proietti V, Del Manso M, Puopolo M, Spuri M, Morciano C, D'Ancona FP, Da Cas R, Battilomo S, Bella A, Menniti-Ippolito F; Italian Integrated Surveillance of COVID-19 study group; on behalf of the Italian COVID-19 vaccines registry. Mateo-Urdiales A, et al. Among authors: battilomo s. Euro Surveill. 2021 Jun;26(25):2100507. doi: 10.2807/1560-7917.ES.2021.26.25.2100507. Euro Surveill. 2021. PMID: 34169819 Free PMC article.
[The health determinants in young children: testing a new surveillance system in Italy].
Pizzi E, Spinelli A, Battilomo S, Azzarito C, Balducci MT, Bettinelli ME, Campostrini S, Germinario C, Mazzarella G, Mignuoli AD, Morbidoni M, Porchia S, Simeoni L, Speri L; Gruppo sorveglianza bambini 0-2 anni. Pizzi E, et al. Among authors: battilomo s. Epidemiol Prev. 2019 Jan-Feb;43(1):66-70. doi: 10.19191/EP19.1.P66.022. Epidemiol Prev. 2019. PMID: 31111715 Free article. Italian.
Long term mortality and morbidity of Italian soldiers after deployment in Iraq as related to biomarkers assessment: Results of the SIGNUM study.
De Angelis R, Piciocchi A, Bugani M, Rossi S, Lastilla M, Vento R, Autore A, Sebastiani N, Palomba S, Manno V, Battilomo S, Belmonte S, Pulliero A, Izzotti A. De Angelis R, et al. Among authors: battilomo s. Environ Res. 2022 Aug;211:113029. doi: 10.1016/j.envres.2022.113029. Epub 2022 Feb 26. Environ Res. 2022. PMID: 35227675
Consensus paper on postural dysfunction: recommendations for prevention, diagnosis and therapy.
Saggini R, Anastasi GP, Battilomo S, Maietta Latessa P, Costanzo G, Di Carlo F, Festa F, Giardinelli G, Macrì F, Mastropasqua L, Nardone M, Nicoletti G, Orsini A, Pastorelli M, Pellegrino R, Trevisan M, La Mesa L, Le Pera AM, Privitera MG, Ralli G, Villani C, Bricot B, Davidson RG, Hassdenteufel A, Hawamdeh ZM, Kleinrensink GJ, Matheron E, Stoev VL, Stratulat S, Tiron S, Villeneuve P, Paolucci T, Bellomo RG. Saggini R, et al. Among authors: battilomo s. J Biol Regul Homeost Agents. 2021 Mar-Apr;35(2):441-456. doi: 10.23812/20-743-A. J Biol Regul Homeost Agents. 2021. PMID: 33940790
Effectiveness against severe COVID-19 of a seasonal booster dose of bivalent (original/Omicron BA.4-5) mRNA vaccines in persons aged ≥60 years: Estimates over calendar time and by time since administration during prevalent circulation of different Omicron subvariants, Italy, 2022-2023.
Fabiani M, Mateo-Urdiales A, Sacco C, Fotakis EA, Battilomo S, Petrone D, Del Manso M, Bella A, Riccardo F, Stefanelli P, Palamara AT, Pezzotti P; Italian Integrated Surveillance of COVID-19 study group and of the Italian COVID-19 Vaccines Registry group. Fabiani M, et al. Among authors: battilomo s. Vaccine. 2024 Oct 3;42(23):126026. doi: 10.1016/j.vaccine.2024.05.074. Epub 2024 Jun 3. Vaccine. 2024. PMID: 38834428 Free article.
13 results